Citadel Advisors’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $64.4K | Sell |
38,100
-94,000
| -71% | -$167K | ﹤0.01% | 12294 |
|
|
2025
Q4 | $188K | Buy |
132,100
+53,800
| +69% | +$78.4K | ﹤0.01% | 11095 |
|
|
2025
Q3 | $128K | Buy |
78,300
+52,600
| +205% | +$58.5K | ﹤0.01% | 11652 |
|
|
2025
Q2 | $18.8K | Sell |
25,700
-15,200
| -37% | -$13.1K | ﹤0.01% | 12116 |
|
|
2025
Q1 | $33K | Sell |
40,900
-174,600
| -81% | -$201K | ﹤0.01% | 12723 |
|
|
2024
Q4 | $297K | Buy |
215,500
+186,200
| +635% | +$209K | ﹤0.01% | 9667 |
|
|
2024
Q3 | $30.5K | Sell |
29,300
-1,400
| -5% | -$1.92K | ﹤0.01% | 12420 |
|
|
2024
Q2 | $53.1K | Sell |
30,700
-8,500
| -22% | -$17.1K | ﹤0.01% | 11686 |
|
|
2024
Q1 | $93.7K | Sell |
39,200
-20,100
| -34% | -$49.5K | ﹤0.01% | 11448 |
|
|
2023
Q4 | $197K | Buy |
59,300
+43,200
| +268% | +$116K | ﹤0.01% | 9982 |
|
|
2023
Q3 | $60.2K | Sell |
16,100
-23,300
| -59% | -$108K | ﹤0.01% | 11530 |
|
|
2023
Q2 | $168K | Buy |
39,400
+8,000
| +25% | +$47.2K | ﹤0.01% | 10149 |
|
|
2023
Q1 | $215K | Sell |
31,400
-2,900
| -8% | -$22.5K | ﹤0.01% | 10061 |
|
|
2022
Q4 | $272K | Buy |
+34,300
| New | +$264K | ﹤0.01% | 9530 |
|
|
2022
Q1 | – | Sell |
-19,100
| Closed | -$305K | – | 13671 |
|
|
2021
Q4 | $305K | Sell |
19,100
-2,100
| -10% | -$36.7K | ﹤0.01% | 10879 |
|
|
2021
Q3 | $341K | Buy |
21,200
+3,400
| +19% | +$49.8K | ﹤0.01% | 10768 |
|
|
2021
Q2 | $246K | Sell |
17,800
-10,300
| -37% | -$146K | ﹤0.01% | 11728 |
|
|
2021
Q1 | $411K | Buy |
+28,100
| New | +$477K | ﹤0.01% | 10110 |
|
|
2020
Q4 | – | Sell |
-11,500
| Closed | -$211K | – | 10954 |
|
|
2020
Q3 | $211K | Buy |
+11,500
| New | +$214K | ﹤0.01% | 8718 |
|
|
2019
Q4 | – | Sell |
-14,700
| Closed | -$298K | – | 9159 |
|
|
2019
Q3 | $298K | Buy |
14,700
+2,700
| +23% | +$53.9K | ﹤0.01% | 7560 |
|
|
2019
Q2 | $265K | Sell |
12,000
-8,700
| -42% | -$151K | ﹤0.01% | 7773 |
|
|
2019
Q1 | $282K | Buy |
20,700
+6,400
| +45% | +$85.4K | ﹤0.01% | 7706 |
|
|
2018
Q4 | $129K | Buy |
+14,300
| New | +$165K | ﹤0.01% | 8132 |
|
|
2018
Q3 | – | Sell |
-21,600
| Closed | -$302K | – | 9238 |
|
|
2018
Q2 | $302K | Buy |
+21,600
| New | +$309K | ﹤0.01% | 7194 |
|
|
2017
Q2 | – | Sell |
-9,800
| Closed | -$207K | – | 7531 |
|
|
2017
Q1 | $207K | Buy |
+9,800
| New | +$241K | ﹤0.01% | 6464 |
|
|
2015
Q3 | – | Sell |
-3,800
| Closed | -$110K | – | 8894 |
|
|
2015
Q2 | $110K | Buy |
+3,800
| New | +$96.1K | ﹤0.01% | 6987 |
|
Other funds holding CHRS
VCM
SB
KKRC
CM
CWG